Javier Szwarcberg, Chief Executive Officer at Spruce Biosciences (NASDAQ:SPRB), reported a large acquisition of company stock options on November 29, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Szwarcberg, Chief Executive Officer at Spruce Biosciences, a company in the Health Care sector, was just awarded stock options worth 125,000 shares of SPRB. The options give Szwarcberg the right to buy the company's stock at $4.59 per share.
Spruce Biosciences shares are trading up 1.43% at $1.42 at the time of this writing on Wednesday morning. Since the current price is $1.42, this makes Szwarcberg's 125,000 shares worth $177,500.